HCM
CALC icon

Heights Capital Management’s CalciMedica CALC Stock Holding History

Heights Capital Management’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
+1,556,081
New +$1.1M 0.37% 79

Other funds holding CALC

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Heights Capital Management's CALC Position: Q2 2026 in Review

Heights Capital Management opened a new position in CalciMedica (CALC) in Q2 2026: 1,556,081 shares worth $1.6M. The stake represents 0.37% of the portfolio and ranks #79 among its holdings.

31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

  • Heights Capital Management held 1,556,081 shares of CalciMedica worth $1.6M as of Q2 2026.
  • CalciMedica was a new Heights Capital Management position in Q2 2026.
  • CalciMedica made up 0.37% of Heights Capital Management's portfolio in Q2 2026, its #79 holding.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Heights Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.